Overview

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study is to compare the tolerability of different methods for switching from another medication to duloxetine for the management of diabetic nerve pain. The primary objective is to compare the most gradual method with the most abrupt method, to see if they have different tolerability.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride